E-LIB Suche - Ergebnisse für: Nelhűbel, Györgyi A.

1

EGFR R521K Polymorphism Is Not a Major Determinant of Clini..:

Cserepes, Mihály ; Nelhűbel, Györgyi A. ; Meilinger-Dobra, Mónika...
Cancers. 14 (2022) 10 - p. 2407 , 2022

Link: https://doi.org/10.3390/..

2

EGFR Alterations Influence the Cetuximab Treatment Response..:

Nelhűbel, Györgyi A. ; Cserepes, Mihály ; Szabó, Balázs...
Pathology and Oncology Research. 27 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

3

Clinical significance of genetic alterations and expression..:

Szabó, Balázs ; Nelhűbel, Györgyi A. ; Kárpáti, Adél...
Oral Oncology. 47 (2011) 6 - p. 487-496 , 2011

Link: https://doi.org/10.1016/..

4

EGFR R521K Polymorphism Is Not a Major Determinant of Clini..:

Cserepes, Mihály ; Nelhűbel, Györgyi A ; Meilinger-Dobra, Mónika...
Cancers. -14 : 10 (2022), p. 1-15. -Cancers (Basel). - 2072-6694. , 2022

Link: http://hdl.handle.net/24..

5

EGFR Alterations Influence the Cetuximab Treatment Response..:

Nelhűbel, Györgyi A ; Cserepes, Mihály ; Szabó, Balázs...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262169/. , 2021

Link: http://www.ncbi.nlm.nih...

6

EGFR R521K Polymorphism Is Not a Major Determinant of Clini..:

Mihály Cserepes ; Györgyi A. Nelhűbel ; Mónika Meilinger-Dobra...
https://www.mdpi.com/2072-6694/14/10/2407. , 2022

Link: https://doi.org/10.3390/..

7

EGFR R521K Polymorphism Is Not a Major Determinant of Clini..:

Mihály Cserepes ; Györgyi A. Nelhűbel ; Mónika Meilinger-Dobra...
Cancer Biomarkers. , 2022

Link: https://doi.org/10.3390/..

8

DataSheet1_EGFR Alterations Influence the Cetuximab Treatme..:

Györgyi A. Nelhűbel ; Mihály Cserepes ; Balázs Szabó...
doi:10.3389/pore.2021.620256.s001. , 2021

Link: https://doi.org/10.3389/..

9

DataSheet1_EGFR Alterations Influence the Cetuximab Treatme..:

Györgyi A. Nelhűbel (10736781) ; Mihály Cserepes (10736784) ; Balázs Szabó (8056559)...
https://figshare.com/articles/dataset/DataSheet1_EGFR_Alterations_Influence_the_Cetuximab_Treatment_Response_and_c-MET_Tyrosine-Kinase_Inhibitor_Sensitivity_in_Experimental_Head_and_Neck_Squamous_Cell_Carcinomas_docx/14527812. , 2021

Link: https://doi.org/10.3389/..